Covered recipient · General Payments record
BREANNA LEE BYRD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$8,322.88
- Reported across 375 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,225.28 | 47 |
| Education | $174.94 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $143.58 | 4 |
| ABBVIE INC. | $142.25 | 3 |
| Daiichi Sankyo Inc. | $139.13 | 4 |
| BeiGene USA, Inc. | $125.00 | 1 |
| Regeneron Healthcare Solutions, Inc. | $71.84 | 2 |
| Janssen Biotech, Inc. | $71.46 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $67.80 | 3 |
| PFIZER INC. | $62.54 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $54.33 | 3 |
| TerSera Therapeutics LLC | $49.81 | 2 |
| EMD Serono, Inc. | $48.60 | 2 |
| AVEO Pharmaceuticals, Inc. | $41.61 | 1 |
| Astellas Pharma US Inc | $41.49 | 2 |
| Genmab U.S., Inc. | $39.30 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.05 | 1 |
| JAZZ PHARMACEUTICALS INC. | $28.38 | 1 |
| ADC Therapeutics America, Inc. | $26.89 | 1 |
| Merck Sharp & Dohme Corporation | $24.28 | 1 |
| Tempus AI, Inc | $23.31 | 1 |
| Celgene Corporation | $22.48 | 1 |
| GlaxoSmithKline, LLC. | $20.18 | 1 |
| E.R. Squibb & Sons, L.L.C. | $20.03 | 1 |
| ARRAY BIOPHARMA INC | $19.00 | 1 |
| MorphoSys, US Inc. | $18.62 | 1 |
| EISAI INC. | $17.80 | 1 |
| GENZYME CORPORATION | $16.87 | 1 |
| Mirati Therapeutics, Inc. | $16.68 | 1 |
| TAIHO ONCOLOGY, INC. | $15.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (49)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.